Cipla has been in the news recently after it signed a perpetual license agreement with Novartis Pharma AG to manufacture and market the Galvus range for the treatment of type 2 diabetes on April 10.
India second-largest IT services firm Infosys on Thursday said its consolidated net profit surged by 11.1 per cent year-on-year to Rs 6,021 crore for the seco
India second-largest IT services firm Infosys on Thursday said its consolidated net profit surged by 11.1 per cent year-on-year to Rs 6,021 crore for the seco